Literature DB >> 29228422

MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3.

Y Jin1, L-P Tao, S-C Yao, Q-K Huang, Z-F Chen, Y-J Sun, S-Q Jin.   

Abstract

OBJECTIVE: To dissect the functioning mode of miR-582-5p on gastric cancer cell growth and provide therapeutic targets for gastric cancer. PATIENTS AND METHODS: Relative expression levels of miR-582-5p in human gastric cancer tissue samples and gastric cancer-derived cell lines were measured by using quantitative Real-time PCR. Cell proliferation and viability capacities were assessed by cell counting kit-8 (CCK8) assay and colony formation assay. Cell apoptosis and cell cycle distribution were identified by flow cytometry. Downstream target gene was confirmed by using luciferase and Western blotting assays.
RESULTS: MiR-582-5p was downregulated in gastric cancer tissues when compared with para-carcinoma tissues (n=42). Overexpressed miR-582-5p could attenuate cell proliferation and viability capacities, as well as promoted cell apoptosis and cell cycle arrest at G0/G1 phase. AKT3 was chosen as the target gene of miR-582-5p by bioinformatics analysis and luciferase reporter assay. Moreover, restoration of AKT3 could impair tumor suppression role of miR-582-5p on gastric cancer growth.
CONCLUSIONS: MiR-582-5p exerted tumor-suppressive effects on gastric cancer growth via targeting AKT3 in vitro, which provided an innovative and candidate target for diagnosis and treatment of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29228422     DOI: 10.26355/eurrev_201711_13827

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  15 in total

Review 1.  Current perspectives on the dysregulated microRNAs in gastric cancer.

Authors:  Shirin Azarbarzin; Reza Safaralizadeh; Mahdi Banan Khojasteh; Amir Baghbanzadeh; Behzad Baradaran
Journal:  Mol Biol Rep       Date:  2020-08-09       Impact factor: 2.316

2.  MiR-582-5p Inhibits Bladder Cancer-Genesis by Suppressing TTK Expression.

Authors:  Yudong Tian; Yanbin Guan; Yang Su; Wenjian Luo; Guo Yang; Yu Zhang
Journal:  Cancer Manag Res       Date:  2020-11-20       Impact factor: 3.989

3.  Comparative proteomic analysis uncovers potential biomarkers involved in the anticancer effect of Scutellarein in human gastric cancer cells.

Authors:  Venu Venkatarame Gowda Saralamma; Preethi Vetrivel; Ho Jeong Lee; Seong Min Kim; Sang Eun Ha; Rajeswari Murugesan; Eun Hee Kim; Jeong Doo Heo; Gon Sup Kim
Journal:  Oncol Rep       Date:  2020-07-07       Impact factor: 3.906

4.  MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.

Authors:  Xi Wang; Guang-Hui Li
Journal:  J Cell Physiol       Date:  2018-08-22       Impact factor: 6.384

5.  EGR1 interacts with DNMT3L to inhibit the transcription of miR-195 and plays an anti-apoptotic role in the development of gastric cancer.

Authors:  Yang Yang; Fei Wu; Jing Zhang; Ruifang Sun; Fang Li; Yulong Li; Su'e Chang; Lumin Wang; Xiaofei Wang; Liying Liu; Chen Huang
Journal:  J Cell Mol Med       Date:  2019-09-12       Impact factor: 5.310

6.  Gene regulatory network analysis with drug sensitivity reveals synergistic effects of combinatory chemotherapy in gastric cancer.

Authors:  Jeong Hoon Lee; Yu Rang Park; Minsun Jung; Sun Gyo Lim
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

7.  RUNX1/miR-582-5p Pathway Regulates the Tumor Progression in Clear Cell Renal Cell Carcinoma by Targeting COL5A1.

Authors:  Jianxin Xue; Shenhao Zhu; Feng Qi; Kai Zhu; Pu Cao; Jie Yang; Zengjun Wang
Journal:  Front Oncol       Date:  2021-04-14       Impact factor: 6.244

8.  MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.

Authors:  Sha Li; Jian-Jun Xu; Qing-Yun Zhang
Journal:  Cancer Sci       Date:  2019-08-19       Impact factor: 6.716

9.  MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-κB pathway.

Authors:  Liwei Ruan; Xiaojun Qian
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.976

Review 10.  Exosomes: Insights from Retinoblastoma and Other Eye Cancers.

Authors:  Kashmiri Lande; Jitesh Gupta; Ravi Ranjan; Manjari Kiran; Luis Fernando Torres Solis; Arturo Solís Herrera; Gjumrakch Aliev; Roy Karnati
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.